<DOC>
	<DOCNO>NCT00387309</DOCNO>
	<brief_summary>Primary Objective : In subject undergone segmental colectomy , time end surgery first bowel movement significantly short investigational MOA-728 regimen placebo regimen .</brief_summary>
	<brief_title>Study Evaluating IV Methylnaltrexone Treatment Post Operative Ileus</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion : Must schedule segmental colectomy via open laparotomy general anesthesia Subjects history inflammatory bowel disease eligible long disease currently active criterion meet Subjects must meet American Society Anesthesiologists physical status I , II III Exclusion : Subjects schedule laparoscopic surgery segmental colectomy Subjects recent history ( &lt; 1 year prior randomization ) abdominal radiation therapy ; Subjects history small bowel obstruction , know suspect bowel adhesion ( minor , clinically nonsignificant adhesion ) Subjects undergoing operation result gastrointestinal ostomy , require use post operative nonsteroidal antiinflammatory drug ( NSAIDs )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Bowel</keyword>
</DOC>